10
views
0
recommends
+1 Recommend
0 collections
    1
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The most important aspect of the present study is the finding that the hypotensive and lethal effects of Bacillus anthracis edema toxin are mediated in part via the production of nitric oxide (NO) and that coadministration of an NO synthase inhibitor with edema toxin challenge has a beneficial survival effect .

          Abstract

          We showed previously that Bacillus anthracis edema toxin (ET), comprised of protective antigen (PA) and edema factor (EF), inhibits phenylephrine (PE)-induced contraction in rat aortic rings and these effects are diminished in endothelial-denuded rings. Therefore, employing rat aortic ring and in vivo models, we tested the hypothesis that nitric oxide (NO) contributes to ET's arterial effects. Compared with rings challenged with PA alone, ET (PA + EF) reduced PE-stimulated maximal contractile force (MCF) and increased the PE concentration producing 50% MCF (EC 50) ( P < 0.0001). Compared with placebo, l-nitro-arginine methyl-ester ( l-NAME), an NO synthase (NOS) inhibitor, reduced ET's effects on MCF and EC 50 in patterns that approached or were significant ( P = 0.06 and 0.03, respectively). In animals challenged with 24-h ET infusions, l-NAME (0.5 or 1.0 mg·kg −1·h −1) coadministration increased survival to 17 of 28 animals (60.7%) compared with 4 of 27 (14.8%) given placebo ( P = 0.01). Animals receiving l-NAME but no ET all survived. Compared with PBS challenge, ET increased NO levels at 24 h and l-NAME decreased these increases ( P < 0.0001). ET infusion decreased mean arterial blood pressure (MAP) in placebo and l-NAME-treated animals ( P < 0.0001) but l-NAME reduced decreases in MAP with ET from 9 to 24 h ( P = 0.03 for the time interaction). S-methyl- l-thiocitrulline, a selective neuronal NOS inhibitor, had effects in rings and, at a high dose in vivo models, comparable to l-NAME, whereas N′-[3-(aminomethyl)benzyl]-acetimidamide, a selective inducible NOS inhibitor, did not. NO production contributes to ET's arterial relaxant, hypotensive, and lethal effects in the rat.

          Related collections

          Author and article information

          Journal
          Am J Physiol Heart Circ Physiol
          Am. J. Physiol. Heart Circ. Physiol
          ajpheart
          ajpheart
          AJPHEART
          American Journal of Physiology - Heart and Circulatory Physiology
          American Physiological Society (Bethesda, MD )
          0363-6135
          1522-1539
          22 July 2016
          1 September 2016
          : 311
          : 3
          : H781-H793
          Affiliations
          [1] 1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland; and
          [2] 2National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
          Author notes
          Address for reprint requests and other correspondence: P. Q. Eichacker, Critical Care Medicine Dept., National Institutes of Health, Bldg. 10, Rm. 2C145, 9000 Rockville Pike, Bethesda, MD 20892 (e-mail: peichacker@ 123456mail.cc.nih.gov ).
          Article
          PMC5142181 PMC5142181 5142181 H-00163-2016
          10.1152/ajpheart.00163.2016
          5142181
          27448553
          6c824860-37ca-45ee-99de-1c97578aa184
          History
          : 19 February 2016
          : 19 July 2016
          Funding
          Funded by: The intramural programs of the NIH, clinical center, critical care department
          Funded by: National institutes of allergy and infectious diseases
          Categories
          Integrative Cardiovascular Physiology and Pathophysiology

          anthrax,edema toxin,nitric oxide,NOS inhibitor,hypotension,arterial contraction

          Comments

          Comment on this article